BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Methods Development

WuXi Biologics and BioNTech Partner on Monoclonal Antibody Research Agreement

Under the terms of the agreement, WuXi Biologics leverages its proprietary antibody discovery technology platforms (R in CRDMO) to discover two undisclosed...

January 11, 2024 | News

AGC announces strategic expansion of its Biopharmaceutical CDMO capability in Yokohama, Japan, signaling a new era of innovation and growth

This expansion has been selected by the Japanese Ministry of Economy, Trade and Industry (METI) as part of its "Developing biopharmaceutical manufacturin...

December 26, 2023 | News

WuXi Vaccines Passes First GMP Audit by a Global Vaccine Leader

The three-day comprehensive audit covered the CDMO site's drug substance (DS) facility, drug product (DP) facility, QC laboratories, warehouse, and utiliti...

December 07, 2023 | News

WuXi Biologics Achieves Breakthrough Productivity of ~6 g/L/day in Integrated Continuous Process at Pilot Scale

By leveraging WuXiUPTM, WuXi Biologics has completed its first end-to-end continuous drug substance (DS) manufacturing from perfused cell culture...

November 23, 2023 | News

Aragen Commissions state-of-the-art Formulations Manufacturing Facility in India

This state-of-the-art facility, set up at an investment of USD 3Mn, is located at the Mallapur Campus in Hyderabad and spans over 12,000 square feet area. ...

October 20, 2023 | News

Navin Fluorine International Ltd. unveils "Navin Molecular" as the new brand for its innovative CDMO business

The new brand is being launched to showcase the broad platform that Navin Molecular can offer and will focus on two key value propositions. Firstly, ...

October 17, 2023 | News

Fujirebio and Sysmex Enter into Basic Agreement on Business Collaboration in the Field of Immunoassay

Sysmex has built up a robust technological foundation as well as a global network in the in vitro diagnostics field through developing its busine...

October 11, 2023 | News

Sino Biological Announces the Opening of Its New US-Based Center for Bioprocessing

Headquartered in Beijing, China, Sino Biological is the world’s leading provider of mammalian cell-based recombinant proteins, antibodies, and relate...

October 10, 2023 | News

OBiO Launches GMP Facility Intelli-M for Rapid Delivery of Innovative Therapies

The launch of the new base in Shanghai will enhance OBiO's production and service capabilities in both China and the United States...

September 28, 2023 | News

WuXi Vaccines Launches Its First Vaccines CDMO Site in China

The opening will add drug substance and drug product capacity, with end-to-end services for diversified vaccines that will accelerate global clients' proje...

September 27, 2023 | News

Merck to Become First Provider to Offer Fully Integrated mRNA Services

New sites at Darmstadt and Hamburg complement Merck’s global integrated mRNA service network with pre-clinical to commercial capabilities Company&...

September 27, 2023 | News

4 Ways to Increase Operational Performance

...

September 26, 2023 | News

Chime Biologics Partners with Panolos Bioscience for Multi-specific Protein Development

Chime Biologics, a leading CDMO that enables biologic therapeutics development announced a strategic cooperation agreement with Panolos Bioscience, a South...

September 25, 2023 | News

South Korea's ST Pharm Marks Milestone with Oligonucleotide Facility Ceremony

To diversify its operational scope, the new facility will be designed to accommodate different scales of production. Initially, it will introduce three new...

September 19, 2023 | News

Stay Connected